2,3-bis(4-hydroxyphenyl)-propionitrile has been researched along with Allergic Encephalomyelitis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crawford, DK; Kumar, S; Mangiardi, M; Moore, S; Patel, R; Suwanna, N; Tiwari-Woodruff, SK | 1 |
| Cao, Y; Itoh, N; Spence, RD; Voskuhl, RR; Wisdom, AJ | 1 |
| Du, S; Sandoval, F; Trinh, P; Voskuhl, RR | 1 |
| Du, S; Sandoval, F; Trinh, P; Umeda, E; Voskuhl, R | 1 |
| Lee, R; Morales, LB; Tiwari-Woodruff, S; Voskuhl, RR | 1 |
5 other study(ies) available for 2,3-bis(4-hydroxyphenyl)-propionitrile and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Estrogen receptor β ligand therapy activates PI3K/Akt/mTOR signaling in oligodendrocytes and promotes remyelination in a mouse model of multiple sclerosis.
Topics: Animals; Blotting, Western; Brain-Derived Neurotrophic Factor; Calpain; Caspase 3; Corpus Callosum; Electrophysiological Phenomena; Encephalomyelitis, Autoimmune, Experimental; Estrogen Receptor beta; Female; Immunohistochemistry; Ligands; Male; Mice; Mice, Inbred C57BL; Microscopy, Electron; Multiple Sclerosis; Myelin Sheath; Nitriles; Oligodendroglia; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Postural Balance; Selective Estrogen Receptor Modulators; Signal Transduction; Spinal Cord; TOR Serine-Threonine Kinases | 2013 |
Estrogen receptor-β ligand treatment after disease onset is neuroprotective in the multiple sclerosis model.
Topics: Animals; Axons; Demyelinating Diseases; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Freund's Adjuvant; Mice; Mice, Inbred C57BL; Myelin-Oligodendrocyte Glycoprotein; Neuroprotective Agents; Nitriles; Peptide Fragments; Propionates; Receptors, Estrogen; Severity of Illness Index | 2013 |
Additive effects of combination treatment with anti-inflammatory and neuroprotective agents in experimental autoimmune encephalomyelitis.
Topics: Analysis of Variance; Animals; Antigens, CD; Antigens, Differentiation; Cytokines; Disease Models, Animal; Drug Therapy, Combination; Encephalomyelitis, Autoimmune, Experimental; Female; Glycoproteins; Immunologic Factors; Integrin alpha4beta1; Interferon-beta; Luminescent Proteins; Macrophages; Matrix Metalloproteinase 9; Mice; Mice, Transgenic; Myelin Basic Protein; Myelin-Oligodendrocyte Glycoprotein; Neuroprotective Agents; Neutrophil Infiltration; Nitriles; Peptide Fragments; Propionates; Severity of Illness Index; Spinal Cord | 2010 |
Estrogen receptor-β ligand treatment modulates dendritic cells in the target organ during autoimmune demyelinating disease.
Topics: Adoptive Transfer; Animals; Axons; Dendritic Cells; Encephalomyelitis, Autoimmune, Experimental; Estrogen Receptor beta; Female; Ligands; Mice; Mice, Inbred C57BL; Mice, Knockout; Myelin Sheath; Nitriles; Propionates; Severity of Illness Index; Spinal Cord; Tumor Necrosis Factor-alpha | 2011 |
Differential neuroprotective and antiinflammatory effects of estrogen receptor (ER)alpha and ERbeta ligand treatment.
Topics: Animals; Anti-Inflammatory Agents; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Homozygote; Humans; Immunohistochemistry; Ligands; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Nitriles; Ovariectomy; Phenols; Propionates; Pyrazoles; Selective Estrogen Receptor Modulators | 2007 |